NHO Kinki Chuo Chest Medical Center
In research, NHO Kinki Chuo Chest Medical Center stands highest in Medicine (#8,874 of 10,443 worldwide) and Health Sciences (#10,668 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 21.9× its share of world research.
- World rank, 2022–2025
- #25,997 of 28,054 · #27,048 all time
- Rank in Japan
- #934 of 1,070
- Research works
- 550 ▲ 30% vs 2013–17
- Citations
- 12k 21.0 per fractional work
- Top-10% rate
- 6.0% record average 16.5%
- Open access
- 47% world 28%
What is NHO Kinki Chuo Chest Medical Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,874 of 10,443 | 6.3% | 90 | #8358 | |
| Health SciencesDomain | #10,668 of 11,982 | 6.2% | 92 | #11143 |
Each strip is that field’s whole ranked pool, with the notch where NHO Kinki Chuo Chest Medical Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does NHO Kinki Chuo Chest Medical Center specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 21.9× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 34.1 works22×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 11.3×. Every wedge is a field page.
- Veterinary 11.3×
- Medicine 4.6×
- Immunology and Microbiology 1.4×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Chemistry 0.7×
- Neuroscience 0.3×
- Health Professions 0.2×
- Environmental Science 0.1×
- Nursing 0.1×
- Psychology 0.1×
- Social Sciences 0.0×
- Mathematics 0.0×
- Economics, Econometrics and Finance 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at NHO Kinki Chuo Chest Medical Center?
Ranked on the composite score, Yoshikazu Inoue, Masanori Kitaichi and Akihide Matsumura lead among researchers whose main affiliation is NHO Kinki Chuo Chest Medical Center.
- 1 Yoshikazu Inoue Japan · #6,180 worldwide 829 citations · 116 works
- 2 Masanori Kitaichi Japan · #9,861 worldwide 707 citations · 52 works
- 3 Akihide Matsumura Japan · #120,382 worldwide 139 citations · 28 works
- 4 Masaaki Kawahara Japan · #121,209 worldwide 158 citations · 46 works
- 5 Kazunobu Tachibana Japan · #144,584 worldwide 175 citations · 21 works
- 6 Shigeki Shimizu Japan · #333,979 worldwide 62 citations · 18 works
- 7 Toru Arai Japan · #463,596 worldwide 65 citations · 54 works
- 8 Satoru Yamamoto Japan · #523,527 worldwide 55 citations · 38 works
- 9 Hiromitsu Sumikawa Japan · #565,614 worldwide 41 citations · 19 works
- 10 Masaji Okada Japan · #639,080 worldwide 57 citations · 20 works
Which keywords describe research at NHO Kinki Chuo Chest Medical Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Diagnosis, Treatment, Fibrosis, Interstitial Lung Disease, Epithelial-Mesenchymal Transition, Idiopathic Pulmonary Fibrosis, TGF-ß and Epidemiology.
- Elderly Patients
- Tuberculosis
- Cognitive Impairment
- Pneumothorax
- CT Screening
- Adjuvant Therapy
- Mycobacterium avium
- Prognostic Factors
- Crohn's Disease
- Autoantibodies
- Immune Response
- Antibiotic Resistance
- ALK Inhibitors
- Treatment Guidelines
- Immunotherapy
- Targeted Therapy
- TGF-ß
- Epithelial-Mesenchymal Transition
- Fibrosis
- Diagnosis
- Epidemiology
- Treatment
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Chemotherapy
- Clinical Trials
- Management
- Resistance Mechanisms
- EGFR Mutations
- Radiotherapy
- Tumor Microenvironment
- Metastasis
- Cystic Fibrosis
- Tumor Staging
- Nontuberculous Mycobacteria
- Drug Resistance
- Lung Cancer
- Mechanical Ventilation
- Mycobacterium tuberculosis
- Vaccine
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 3.2×24 topics
- Diagnosis12▲ 13×11 topics
- Treatment12▲ 9.3×12 topics
- Fibrosis11▲ 56×3 topics
- Interstitial Lung Disease10▲ 163×2 topics
- Epithelial-Mesenchymal Transition9▲ 96×2 topics
- Idiopathic Pulmonary Fibrosis9▲ 193×1 topic
- TGF-ß9▲ 58×1 topic
- Chemotherapy8▲ 11×13 topics
- Targeted Therapy8▲ 34×4 topics
- Clinical Trials7▲ 11×4 topics
- Immunotherapy6▲ 8.5×9 topics
- Management6▲ 7.8×12 topics
- Treatment Guidelines5▲ 25×2 topics
- Resistance Mechanisms5▲ 60×2 topics
- ALK Inhibitors5▲ 76×1 topic
- EGFR Mutations5▲ 76×1 topic
- Antibiotic Resistance5▲ 12×5 topics
- Radiotherapy5▲ 12×6 topics
- Immune Response4▲ 6.9×3 topics
- Tumor Microenvironment4▲ 9.0×5 topics
- Autoantibodies4▲ 16×4 topics
- Metastasis4▲ 11×4 topics
- Crohn's Disease4▲ 47×2 topics
- Cystic Fibrosis4▲ 52×2 topics
- Prognostic Factors4▲ 8.1×8 topics
- Tumor Staging4▲ 32×2 topics
- Mycobacterium avium4▲ 104×1 topic
- Nontuberculous Mycobacteria4▲ 104×1 topic
- Adjuvant Therapy3▲ 26×2 topics
- Drug Resistance3▲ 12×4 topics
- CT Screening3▲ 46×1 topic
- Lung Cancer3▲ 18×1 topic
- Pneumothorax3▲ 89×2 topics
- Mechanical Ventilation3▲ 26×2 topics
- Cognitive Impairment3▲ 11×3 topics
- Mycobacterium tuberculosis3▲ 52×1 topic
- Tuberculosis3▲ 55×1 topic
- Vaccine3▲ 7.0×2 topics
- Elderly Patients3▲ 16×3 topics
Which research topics does NHO Kinki Chuo Chest Medical Center publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Treatments and Mutations, Mycobacterium research and diagnosis and Lung Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 9 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 3 Mycobacterium research and diagnosis Epidemiology 4 works
- 4 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 5 Tuberculosis Research and Epidemiology Infectious Diseases 3 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 7 Lung Cancer Research Studies Oncology 2 works
- 8 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 2 works
- 9 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 10 Tracheal and airway disorders Pulmonary and Respiratory Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has NHO Kinki Chuo Chest Medical Center's research output changed?
Output in 2018–2022 was 30% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Osaka
- The University of Osaka
- Osaka City University
- Kindai University
- National Cerebral and Cardiovascular Center
- Kansai Medical University
- Takeda (Japan)
- Osaka International Cancer Institute
- Osaka Institute of Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.